Nanogen last week reported a decline in its fiscal 2004 second-quarter revenues and an increase in its net loss, as the firm struggled with lagging sales of its molecular diagnostics products to clinical laboratories.

The San Diego-based firm posted revenues of $1.1 million for the quarter, compared to $1.7 million for the comparable quarter in 2003. Its product revenues were $477,000 for the quarter, down from product revenues of $662,000 in the second quarter of 2003.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.